Filter
2839
Filtered Results: 2839
Text search:
Impact
analysis
of
tuberculosis
Featured
Recommendations
243
New Publications
790
Language
Document type
No document type
1770
Studies & Reports
519
Guidelines
278
Manuals
110
Strategic & Response Plan
98
Fact sheets
19
Situation Updates
17
Training Material
16
Infographics
6
Resource Platforms
5
Brochures
1
Countries / Regions
Global
107
India
87
Kenya
83
Western and Central Europe
68
South Africa
67
Uganda
65
Ethiopia
63
Nigeria
58
Malawi
56
Nepal
55
Liberia
52
Zambia
50
Tanzania
47
Rwanda
46
Africa
44
Myanmar / Burma
44
Sierra Leone
43
Ukraine
40
Latin America and the Carribbean
39
Bangladesh
36
Ghana
35
Eastern Europe
34
Namibia
34
Lesotho
31
Asia
29
Cambodia
24
Zimbabwe
22
South–East Asia Region
22
Philippines
21
Russia
19
Indonesia
19
Senegal
18
Mozambique
18
Botswana
18
Colombia
16
Congo, Democratic Republic of
14
East and Southern Africa
13
South Sudan
13
Syria
11
Burkina Faso
11
Haiti
11
Peru
9
Germany
9
Moldova
9
Pakistan
9
Tajikistan
8
Cameroon
8
Albania
8
Venezuela
8
West and Central Africa
8
Argentina
8
Benin
7
Afghanistan
7
Eastern Europe and Central Asia
7
Thailand
6
Brazil
6
Yemen
6
Georgia
6
Eswatini/ Swaziland
6
Chile
5
Guinea
5
Middle East and North Africa
5
Sudan
5
Somalia
5
Timor Leste/ East Timor
4
Jordan
4
Paraguay
4
North America
4
Lebanon
4
North Macedonia
3
Mexico
3
El Salvador
3
Laos
3
Jamaica
3
Bolivia
3
Vietnam
3
Papua New Guinea
3
Sri Lanka
3
Central African Republic
3
Madagascar
3
Gambia
2
China
2
Iran
2
Estonia
2
Morocco
2
Bulgaria
2
USA
2
Hungary
2
Saudi Arabia
2
Western Pacific Region
2
Turkmenistan
2
Japan
2
Romania
2
Palestine
2
Poland
2
Honduras
2
Mali
2
Bhutan
2
Iraq
2
Ecuador
2
North Korea
1
Togo
1
Kyrgyzstan
1
Burundi
1
Mongolia
1
Qatar
1
Armenia
1
Gabon
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Southern Africa
1
Nicaragua
1
Djibouti
1
Egypt
1
Slovakia
1
Greece
1
Chad
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1154
Clinical Guidelines
213
Public Health
168
Women & Child Health
85
Key Resources
82
Pharmacy & Technologies
32
Capacity Building
20
Toolboxes
HIV
448
TB
430
COVID-19
148
AMR
127
Mental Health
71
NCDs
60
Global Health Education
56
Health Financing Toolbox
54
Rapid Response
53
Planetary Health
51
Pharmacy
47
NTDs
42
Caregiver
40
Conflict
40
Refugee
35
Ebola
32
Disability
29
Polio
19
Natural Hazards
15
Cholera
3
Specific Hazards
2
Social Ethics
2
South Sudan
1
Health Financing
1
Zika
1
A practical approach for developing policy and strategy to improve quality of care
The handbook outlines an approach for the development of national policies and strategies to improve the quality of care. Such policy and strategy can help clarify the structures, roles and responsibilities within n...
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidan...
Conflict, in its active or latent forms, is everywhere. The COVID-19 pandemic has demonstrated that public health emergencies can strike any country at any time. Given the universality of and interconnections between conflict, humanitarian crises, and public health emergencies, practitioners trained...
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati...
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe...
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
This integrated operational framework provides an overview of the connections between mental health, neurological and substance use (MNS) conditions, and their links to health, well-being and the broader public health and sustainable development agenda. The need for integrated approaches is increasi...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
This report shows that increased domestic revenues can and will cover only part of the necessary SDG budget spending of the LIDCs. Achieving the SDGs in the LIDCs will also require increases of both Official Development Assistance (ODA) and Private Development Assistance (PDA) to reach aggregate lev...
Climate change is a growing concern for Bangladesh because 90 percent of the country is approximately 10 feet above sea level. An evaluation was completed which discovered that high tides in Bangladesh were increasing 10 times more rapidly than the global average. This predicted rapid increase in se...
People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
In 2015, 26% of the deaths of 5.9 million children who died before reaching their fifth birthday could have been prevented
through addressing environmental risks – a shocking missed opportunity. The prenatal and early childhood period represents
a window of particular vulnerability, where enviro...
UNAIDS leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. It unites the efforts of 11 UN Cosponsor organizations- UNHCR, UNICEF, WFP, UNDP,UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank- and a Secretari...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N...
Health system resilience is not an inevitable byproduct of any investment in health but must be intentionally programmed and developed with necessary input, investment and contextualization. This technical product aims to guide national, subnational, and global health actors to operationalize the co...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
